Literature DB >> 10206822

Positron emission tomography in the study of hepatic encephalopathy.

A H Lockwood1.   

Abstract

Positron-emission tomography (PET) is a quantitative technique that produces images of biological or physiological processes. The nature of the image depends on the tracer used: common tracers used to study HE include 18F-fluordeoxyglucose, a marker of glucose metabolism; 15O-water, a marker of cerebral blood flow; and 13N-ammonia, a marker of ammonia metabolism. Combined blood flow and ammonia metabolism studies can be used to calculate the permeability surface area product for ammonia at the blood brain barrier. To take full advantage of PET, the data should be analyzed using one of the several sophisticated image processing and analysis techniques that are available. Thus, PET is an ideal technique to evaluate ammonia metabolism and, because of a close linkage of blood flow and glucose metabolism with neural activity, to investigate the neural response to drugs and other treatments and to examine neural systems that mediate specific tasks that are impaired in patients with HE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10206822     DOI: 10.1023/a:1020684724992

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  10 in total

1.  Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy.

Authors:  A H Lockwood; E W Yap; H M Rhoades; W H Wong
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

2.  Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

Authors:  A H Lockwood; E W Yap; W H Wong
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

Review 3.  The attention system of the human brain.

Authors:  M I Posner; S E Petersen
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

4.  Cerebral uptake of benzodiazepine measured by positron emission tomography in hepatic encephalopathy.

Authors:  Y Samson; J Bernuau; S Pappata; C Chavoix; J C Baron; M A Maziere
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

5.  Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction.

Authors:  G Pomier-Layrargues; J F Giguère; J Lavoie; B Willems; R F Butterworth
Journal:  Hepatology       Date:  1989-12       Impact factor: 17.425

6.  Factors that affect the uptake of ammonia by the brain: the blood-brain pH gradient.

Authors:  A H Lockwood; R D Finn; J A Campbell; T B Richman
Journal:  Brain Res       Date:  1980-01-13       Impact factor: 3.252

7.  Blood and brain ammonia concentrations after portacaval anastomosis. Effects of acute ammonia loading.

Authors:  M Ehrlich; F Plum; T E Duffy
Journal:  J Neurochem       Date:  1980-06       Impact factor: 5.372

8.  The metabolic fate of 13N-labeled ammonia in rat brain.

Authors:  A J Cooper; J M McDonald; A S Gelbard; R F Gledhill; T E Duffy
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

9.  Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy.

Authors:  A H Lockwood; B W Murphy; K Z Donnelly; T C Mahl; S Perini
Journal:  Hepatology       Date:  1993-11       Impact factor: 17.425

10.  The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia.

Authors:  A H Lockwood; J M McDonald; R E Reiman; A S Gelbard; J S Laughlin; T E Duffy; F Plum
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

  10 in total
  3 in total

1.  Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale.

Authors:  Sergei Mechtcheriakov; Ivo-W Graziadei; André Kugener; Julia Wiedemann; Chantal Galbavy; Hartmann Hinterhuber; Josef Marksteiner; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

Review 2.  Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy.

Authors:  V-P Bob Grover; M-Alex Dresner; Daniel-M Forton; Serena Counsell; David-J Larkman; Nayna Patel; Howard-C Thomas; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

Review 3.  Hepatic encephalopathy.

Authors:  Wissam Bleibel; Abdullah M S Al-Osaimi
Journal:  Saudi J Gastroenterol       Date:  2012 Sep-Oct       Impact factor: 2.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.